Suppr超能文献

膀胱腺癌

Adenocarcinoma of the urinary bladder.

作者信息

Dadhania Vipulkumar, Czerniak Bogdan, Guo Charles C

机构信息

Department of Pathology, The University of Texas MD Anderson Cancer Center Houston, TX 77030, USA.

出版信息

Am J Clin Exp Urol. 2015 Aug 8;3(2):51-63. eCollection 2015.

Abstract

Adenocarcinoma is an uncommon malignancy in the urinary bladder which may arise primarily in the bladder as well as secondarily from a number of other organs. Our aim is to provide updated information on primary and secondary bladder adenocarcinomas, with focus on pathologic features, differential diagnosis, and clinical relevance. Primary bladder adenocarcinoma exhibits several different growth patterns, including enteric, mucinous, signet-ring cell, not otherwise specified, and mixed patterns. Urachal adenocarcinoma demonstrates similar histologic features but it can be distinguished from bladder adenocarcinoma on careful pathologic examination. Secondary bladder adenocarcinomas may arise from the colorectum, prostate, endometrium, cervix and other sites. Immunohistochemical study is valuable in identifying the origin of secondary adenocarcinomas. Noninvasive neoplastic glandular lesions, adenocarcinoma in situ and villous adenoma, are frequently associated with bladder adenocarcinoma. It is also important to differentiate bladder adenocarcinoma from a number of nonneoplastic lesions in the bladder. Primary bladder adenocarcinoma has a poor prognosis largely because it is usually diagnosed at an advanced stage. Urachal adenocarcinoma shares similar histologic features with bladder adenocarcinoma, but it has a more favorable prognosis than bladder adenocarcinoma, partly due to the relative young age of patients with urachal adenocarcinoma.

摘要

腺癌是膀胱中一种不常见的恶性肿瘤,它既可以原发于膀胱,也可以继发于其他多个器官。我们的目的是提供有关原发性和继发性膀胱腺癌的最新信息,重点关注病理特征、鉴别诊断和临床相关性。原发性膀胱腺癌表现出几种不同的生长模式,包括肠型、黏液型、印戒细胞型、未另行规定型和混合型。脐尿管腺癌表现出相似的组织学特征,但通过仔细的病理检查可将其与膀胱腺癌区分开来。继发性膀胱腺癌可能起源于结直肠、前列腺、子宫内膜、宫颈和其他部位。免疫组织化学研究对于确定继发性腺癌的起源很有价值。非侵袭性肿瘤性腺性病变、原位腺癌和绒毛状腺瘤常与膀胱腺癌相关。将膀胱腺癌与膀胱中的一些非肿瘤性病变区分开来也很重要。原发性膀胱腺癌预后较差,主要是因为它通常在晚期才被诊断出来。脐尿管腺癌与膀胱腺癌具有相似的组织学特征,但它的预后比膀胱腺癌更好,部分原因是脐尿管腺癌患者相对年轻。

相似文献

1
Adenocarcinoma of the urinary bladder.
Am J Clin Exp Urol. 2015 Aug 8;3(2):51-63. eCollection 2015.
3
5
Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.
Adv Anat Pathol. 2016 Mar;23(2):71-83. doi: 10.1097/PAP.0000000000000110.
6
Bladder Adenocarcinoma: A Persisting Diagnostic Dilemma.
J Clin Diagn Res. 2017 Mar;11(3):ER01-ER04. doi: 10.7860/JCDR/2017/24590.9536. Epub 2017 Mar 1.
7
Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
Am J Surg Pathol. 2012 Mar;36(3):432-42. doi: 10.1097/PAS.0b013e31823fe49c.
8
Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
Am J Surg Pathol. 2007 Sep;31(9):1323-9. doi: 10.1097/PAS.0b013e31802ff7c4.
9
Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
Hum Pathol. 2009 Jan;40(1):108-16. doi: 10.1016/j.humpath.2008.06.022. Epub 2008 Sep 11.
10

引用本文的文献

1
Urinary bladder collision tumors: A case report and literature review.
Med Int (Lond). 2025 Mar 7;5(3):26. doi: 10.3892/mi.2025.225. eCollection 2025 May-Jun.
2
One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract.
Curr Treat Options Oncol. 2024 Feb;25(2):206-219. doi: 10.1007/s11864-024-01187-3. Epub 2024 Feb 5.
4
Bladder colloid carcinoma: A case report.
Urol Case Rep. 2023 May 1;48:102415. doi: 10.1016/j.eucr.2023.102415. eCollection 2023 May.
8
Clinicopathological Characteristics and Prognostic Factors of Primary Bladder Signet Ring Cell Carcinoma.
J Healthc Eng. 2022 Sep 5;2022:3224616. doi: 10.1155/2022/3224616. eCollection 2022.
10
Survival of Patients With UrAC and Primary BAC and Urothelial Carcinoma With Glandular Differentiation.
Front Oncol. 2022 May 12;12:860133. doi: 10.3389/fonc.2022.860133. eCollection 2022.

本文引用的文献

3
Variant histology: role in management and prognosis of nonmuscle invasive bladder cancer.
Curr Opin Urol. 2014 Sep;24(5):517-23. doi: 10.1097/MOU.0000000000000089.
4
GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder.
Am J Surg Pathol. 2013 Nov;37(11):1756-60. doi: 10.1097/PAS.0b013e31829cdba7.
6
GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.
Hum Pathol. 2013 Jul;44(7):1341-9. doi: 10.1016/j.humpath.2012.11.003. Epub 2013 Jan 31.
9
GATA-3 expression in male and female breast cancers: comparison of clinicopathologic parameters and prognostic relevance.
Hum Pathol. 2013 Jun;44(6):1065-70. doi: 10.1016/j.humpath.2012.09.010. Epub 2012 Dec 23.
10
Urachal adenocarcinoma: a clinician's guide for treatment.
Semin Oncol. 2012 Oct;39(5):619-24. doi: 10.1053/j.seminoncol.2012.08.011.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验